Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN11031 in COPD-associated cachexia
2007-007725-46Phase 2Completed
- Sponsor
- Asubio Pharma
- Start
- Aug 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SUN11031 in cachexia (3 arms), sponsored by Asubio Pharma. Primary endpoint: Change in 6-minute walk test distance at Day 85. Started Aug 2008; status: completed.
02
Drugs
SUN11031
03
Conditions
cachexia
Beyond the preview
Go deeper on 2007-007725-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007725-46.